chartexchange

MREO
Mereo BioPharma Group plc
stockNASDAQADR

At CloseNov 18, 2026 3:59:30 PM EST
0.2914USD+6.157%(+0.0169)859,631
After-hoursNov 18, 2026 4:40:30 PM EST
0.2935USD+0.721%(+0.0021)
Loading…
Loading…
Healthcare
Biotechnology
HQ
London, London, United Kingdom
Previous Close
$0.27
Beta
1.47
52-Week High
$2.37 2025-12-11
52-Week Low
$0.20 2025-12-29
SMA 50
$0.31
SMA 200
$0.32
Avg. Vol 10D
928,266
Avg. Vol 30D
762,557
Avg. Vol 90D
3.08M
Relative Vol
1.13
159.70M
159.69M
1.7900%
7,600,000
64,999
Mar 18, 2027 (119d)
MREO Profile

mereo is a new uk-based speciality biopharmaceutical company focussed on the acquisition and rapid development of innovative medicines that have the potential to transform patient quality of life and improve human health. mereo intends to optimise the commercial value of programmes by entering into partnering deals at key value inflection points or, for selected opportunities, commercialising products itself. mereo is building a strong pipeline of innovative medicines, particularly focused in rare and specialist disease areas, through the acquisition of validated, mid-stage development programmes from large biopharmaceutical companies. mereo has access to an extensive network of experts with experience across multiple clinical disciplines for the clinical development of its portfolio.

MREO Performance
PeriodPriceDateChangeBeta
1W0.312026-11-11-4.96%1.240
1M0.302026-10-19-3.54%1.827
3M0.312026-08-18-6.90%1.607
6M0.242026-05-18+22.75%1.418
1Y1.822025-11-18-83.99%1.468
2Y3.332024-11-18-91.25%—
5Y2.062021-11-18-85.85%1.271
MREO Stock Summary

Mereo BioPharma Group plc (NASDAQ:MREO) stock price today is $0.29, and today's volume is 864,436. MREO is up 6.157% today. The 30 day average volume is 762,557. MREO market cap is $46.54M with 159.70M shares outstanding.